FDA
approval
· 2022-02-16
FDA Approved: JUNEL FE 24 — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for JUNEL FE 24, a combined oral contraceptive containing norethindrone acetate and ethinyl estradiol with ferrous f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for JUNEL FE 24 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)